Quantity vs. quality: Long-term use of bone-building osteoporosis drugs
Wednesday, March 10, 2010 - 08:21
in Health & Medicine
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Read the whole article on Physorg
More from Physorg
Related
- Quantity vs. quality: Long-term use of bone-building osteoporosis drugsWed, 10 Mar 2010, 8:24:23 EST
- Long-term use of osteoporosis medication associated with increased risk of atypical fracturesTue, 22 Feb 2011, 17:22:20 EST
- New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patientsTue, 14 Sep 2010, 0:42:35 EDT
- American Academy of Orthopaedic Surgeons approves new guideline for the treatment of pediatric diaphyseal femur fracturesWed, 22 Jul 2009, 11:50:20 EDT
- Taking a break from osteoporosis drugs can protect bonesThu, 18 Nov 2010, 14:53:33 EST